Pharmacovigilance-related recommendations to product information for centrally authorised veterinary medicines

The European Medicines Agency's (EMA) Committee for Veterinary Medicinal Products (CVMP) issues recommendations on updating the product information for centrally authorised veterinary medicines, based on an evaluation of safety data. The marketing authorisation holder of the medicine is responsible for implementing these CVMP recommendations.
VeterinaryPharmacovigilance

EMA maintains a document compiling all CVMP recommendations for product information updates each year. EMA updates the document each month to reflect the latest recommendations following CVMP plenary meetings.

This aims to ensure stakeholders have timely access to the latest recommended product information updates for the safe and efficacious use of veterinary medicines.

For more information on specific medicines, visit the Veterinary Medicines Information website.

Recommendations

Share this page